Accurate and Reproducible Measurement of PD-1/PD-L1Video Categories: PMO Interview with the Innovator Series: Volume 12 and Video Library
Drs. Geoff Oxnard and Lauren Ritterhouse discuss PD-1/PD-L1 as a routine biomarker test run on all lung cancer biopsy specimens, as well as on other selected cancer types, and how qualitative and quantitative results are typically reported.
Dr. S. Yosuf Zafar questions how to incorporate new agents into the standard of cancer care as many of these agents are both expensive and only useful for a small segment of patients.
Ruben A. Mesa, MD, Mayo Clinic, Scottsdale Arizona describes why the need for cytoreductive therapy is evolving Supported through funding from Incyte